
180 Life Sciences Corp (NASDAQ:ATNF), now operating as "ETHZilla," saw its stock jump 12.3% after closing a $425 million private placement. The biotech firm raised capital at $2.65 per share from crypto-focused investors, including Electric Capital and Harbour Island, to fund a new Ethereum treasury strategy, with the majority of proceeds earmarked for ETH purchases. Electric Capital will manage these assets through an "on-chain yield generation program," signifying a major strategic pivot for the company, which also plans to continue legacy iGaming operations and monetize its biotech intellectual property.
180 Life Sciences Corp. (ATNF) has executed a radical strategic pivot, rebranding as "ETHZilla" and shifting its primary focus from biotechnology to a crypto-asset strategy. The company's stock responded with a 12.3% increase following the announcement of a $425 million private investment in public equity (PIPE) transaction priced at $2.65 per share. This capital raise, led by prominent crypto-focused investors such as Electric Capital and Polychain Capital, will predominantly fund the acquisition of Ethereum (ETH). The company's new model is that of a hybrid entity, as it will retain its legacy iGaming operations and seek to monetize its biotech intellectual property while its core treasury is actively managed in the DeFi space. Governance has been overhauled to support this new direction, with a new Chairman and directors appointed, and Electric Capital serving as the external asset manager to implement a high-yield strategy involving staking, lending, and liquidity provisioning. This transformation fundamentally alters the company's risk profile, making its valuation contingent on the volatile crypto markets, the execution of a complex on-chain yield program, and the uncertain value of its legacy assets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment